Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322

Expensive Performer

Download real time

1001.05 -64.35 (-6.04%)

25.02% Fall from 52W High

104.6K NSE+BSE Volume

NSE 04 Apr, 2025 3:31 PM (IST)

12,266.6

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Alivus Life Sciences Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Alivus Life Sciences Ltd. from all sources in a single place.

Load latest

VOTE: Is Glenmark Life Sciences Ltd. worth buying?

120 Votes:

Buy 75.0%

Sell 13.33%

Hold 11.67%

RESEARCH REPORTS

Buy SEE REPORTS >

Hold SEE REPORTS >